DK126992B - Analogifremgangsmåde til fremstilling af 1,2α-methylen-6,7α-dihalogenmethylen-20-spirox-4-en-3-on-forbindelser. - Google Patents

Analogifremgangsmåde til fremstilling af 1,2α-methylen-6,7α-dihalogenmethylen-20-spirox-4-en-3-on-forbindelser.

Info

Publication number
DK126992B
DK126992B DK243670AA DK243670A DK126992B DK 126992 B DK126992 B DK 126992B DK 243670A A DK243670A A DK 243670AA DK 243670 A DK243670 A DK 243670A DK 126992 B DK126992 B DK 126992B
Authority
DK
Denmark
Prior art keywords
spirox
dihalomethylene
methylene
compounds
preparation
Prior art date
Application number
DK243670AA
Other languages
Danish (da)
English (en)
Inventor
G Arth
G Rasmusson
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK126992B publication Critical patent/DK126992B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK243670AA 1969-05-14 1970-05-13 Analogifremgangsmåde til fremstilling af 1,2α-methylen-6,7α-dihalogenmethylen-20-spirox-4-en-3-on-forbindelser. DK126992B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82467269A 1969-05-14 1969-05-14
US2118370A 1970-03-19 1970-03-19

Publications (1)

Publication Number Publication Date
DK126992B true DK126992B (da) 1973-09-10

Family

ID=26694377

Family Applications (3)

Application Number Title Priority Date Filing Date
DK243670AA DK126992B (da) 1969-05-14 1970-05-13 Analogifremgangsmåde til fremstilling af 1,2α-methylen-6,7α-dihalogenmethylen-20-spirox-4-en-3-on-forbindelser.
DK377671AA DK127505B (da) 1969-05-14 1971-08-02 Analogifremgangsmåde til fremstilling af 3,21-dioxygenerede 1,2α-methylen-6,7α-dihalogenmethylen-20-spirox-4-en-forbindelser.
DK590571AA DK127880C (da) 1969-05-14 1971-12-02 Analogifremgangsmåde til fremstilling af 3-oxo-1,2α-methylen-??dihalogenmethylen-20-spirox-4-en-forbindelser.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK377671AA DK127505B (da) 1969-05-14 1971-08-02 Analogifremgangsmåde til fremstilling af 3,21-dioxygenerede 1,2α-methylen-6,7α-dihalogenmethylen-20-spirox-4-en-forbindelser.
DK590571AA DK127880C (da) 1969-05-14 1971-12-02 Analogifremgangsmåde til fremstilling af 3-oxo-1,2α-methylen-??dihalogenmethylen-20-spirox-4-en-forbindelser.

Country Status (17)

Country Link
JP (1) JPS532865B1 (enrdf_load_html_response)
AR (1) AR192305A1 (enrdf_load_html_response)
BE (1) BE750330A (enrdf_load_html_response)
CA (1) CA926385A (enrdf_load_html_response)
CH (2) CH547785A (enrdf_load_html_response)
CS (2) CS151552B2 (enrdf_load_html_response)
DE (1) DE2023450C3 (enrdf_load_html_response)
DK (3) DK126992B (enrdf_load_html_response)
FI (2) FI47355C (enrdf_load_html_response)
FR (1) FR2051526B1 (enrdf_load_html_response)
GB (1) GB1265444A (enrdf_load_html_response)
IE (1) IE34194B1 (enrdf_load_html_response)
IL (1) IL34431A (enrdf_load_html_response)
NL (1) NL168844C (enrdf_load_html_response)
NO (1) NO131131C (enrdf_load_html_response)
SE (2) SE366305B (enrdf_load_html_response)
YU (1) YU34052B (enrdf_load_html_response)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356677A (en) * 1966-04-05 1967-12-05 Syntex Corp 1alpha, 2alpha-and 6alpha, 7alpha-dihalomethylene androstenes

Also Published As

Publication number Publication date
DK127880C (da) 1974-06-10
CH547792A (de) 1974-04-11
YU117670A (en) 1978-05-15
GB1265444A (enrdf_load_html_response) 1972-03-01
FI47355C (fi) 1973-11-12
DK127880B (enrdf_load_html_response) 1974-01-28
FR2051526B1 (enrdf_load_html_response) 1974-04-12
CS151551B2 (enrdf_load_html_response) 1973-10-19
CA926385A (en) 1973-05-15
NL168844C (nl) 1982-05-17
FR2051526A1 (enrdf_load_html_response) 1971-04-09
CH547785A (de) 1974-04-11
IE34194L (en) 1970-11-14
AR192305A1 (es) 1973-02-14
NO131131C (enrdf_load_html_response) 1975-04-09
NL7006474A (enrdf_load_html_response) 1970-11-17
DK127505B (da) 1973-11-19
SE386904B (sv) 1976-08-23
IE34194B1 (en) 1975-03-05
FI47885C (fi) 1974-04-10
CS151552B2 (enrdf_load_html_response) 1973-10-19
DE2023450B2 (de) 1978-10-05
SE366305B (enrdf_load_html_response) 1974-04-22
DE2023450C3 (de) 1979-05-31
IL34431A (en) 1974-03-14
NL168844B (nl) 1981-12-16
DE2023450A1 (de) 1971-01-14
JPS532865B1 (enrdf_load_html_response) 1978-02-01
IL34431A0 (en) 1970-07-19
FI47355B (enrdf_load_html_response) 1973-07-31
YU34052B (en) 1978-10-31
BE750330A (fr) 1970-11-13
NO131131B (enrdf_load_html_response) 1974-12-30
FI47885B (enrdf_load_html_response) 1974-01-02

Similar Documents

Publication Publication Date Title
DK125794B (da) Analogifremgangsmåde til fremstilling af 2,3-dichlorphenoxyeddikesyrederivater.
DK130306B (da) Analogifremgangsmåde til fremstilling af S-trialkylphosphinguld-1-thio-β-D-glucopyranosider.
DK136314B (da) Analogifremgangsmåde til fremstilling af benzamidoethylpiperaziner.
DK132174B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK127113B (da) Analogifremgangsmåde til fremstilling af 1,4-dihydropyridiner.
DK140697B (da) Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin.
DK140842B (da) Fremgangsmåde til fremstilling af 8,9-didebydro-10alfa-alkoxy-ergolener.
DK133375B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-phenylpyrrolidiner.
DK125990B (da) Fremgangsmåde til fremstilling af 4,4'-ditiobis-(2,6-di-t-butylfenol).
DK123232B (da) Analogifremgangsmåde til fremstilling af 3-alkoxy-17α-propinylestra-1,3,5(10)-trien-17β-oler.
DK128006B (da) Analogifremgangsmåde til fremstilling af 11-desacetoxy-wortmannin.
DK123353B (da) Analogifremgangsmåde til fremstilling af 6,7-methylen-20-spirox-4-en-3-on-forbindelser.
DK126504B (da) Fremgangsmåde til fremstilling af 1,2-disubstituerede 4-pyrazolidinoler.
DK127812B (da) Analogifremgangsmåde til fremstilling af 3,5-dibrom-zearalan.
DK127421B (da) Fremgangsmåde til fremstilling af cardenolid-3[2',3'-didesoxyglycosider].
DK127778B (da) Fremgangsmåde til fremstilling af 3',4'-dideoxy-kenamycin B.
DK126654B (da) Analogifremgangsmåde til fremstilling af 2-hydroxymethyl-3-carboxylsyreamido-quinoxalin-di-N-oxider-(1,4).
DK128737B (da) Analogifremgangsmåde til fremstilling af 6α-methyl-17α-caproyloxy-19-norprogesteron.
DK124331B (da) Analogifremgangsmåde til fremstilling af 14β-hydroksy-15α-acyloksy-4,20(22)-kardadienolider.
DK124686B (da) Analogifremgangsmåde til fremstilling af bis-thiachromonylforbindelser.
DK123818B (da) Fremgangsmåde til fremstilling af 14β-hydroxy-card-20(22)-enolider eller -bufa-20,20-dienolider.
DK123816B (da) Analogifremgangsmåde til fremstilling af N-phenacylcarbamater.
DK122127B (da) Analogifremgangsmåde til fremstilling af 3-phenyl-4-acyloxycarbostyriler.
DK122456B (da) Fremgangsmåde til fremstilling af quinoxalin-di-N-oxid-aldehyd.
DK121440B (da) Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner.